Chemotherapy With Monoclonal Antibody and Radioimmunotherapy for High-Risk B-Cell Non-Hodgkins Lymphoma

Inclusion Criteria

• •Untreated, biopsy proven B-cell non-Hodgkin's lymphoma
• •Age \>/= 18 years
• •No other prior malignancy except for adequately treated basal cell or squamous cell skin cancer, in situ cervical cancer, or other cancer for which the patient has been disease-free for one year. The patient cannot have been exposed to chemotherapy to treat any of these diseases for at least 3 years prior to study entry.
• •Meet staging studies and laboratory tests prior to induction, consolidation and radioimmunotherapy.